Summary
Curemark LLC
Founded in 2006
Description
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological and other disorders.
Strengths
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Curemark LLC has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Variance of revenue growth is more than the industry average
- Since Curemark LLC was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
Curemark LLC's annual revenue
$4555000
Based on Kona Equity data
-
Revenue per employee
$284688
-
Variance of revenue growth
1.66
-
Annual revenue growth since founding
$253055
-
Revenue growth rate from first known quarter to current
87.3%
Employee Count
16 employees
-
Employee growth rate from first known quarter to current
84.6%
Executives
Matthew Heil
Senior VP, Drug Development
m**@curemark.comChiwon Yang
Vice President, Manufacturing Sciences & Technology
c**@curemark.comWilliam Gannon
Medical Director
w**@curemark.comKristin Walsh
Director, Clincal Operations
k**@curemark.comJanice Hughes
Director, Investments
j**@curemark.comJoan Fallon
CEO
j**@curemark.comJennifer Katritos
Chief Financial Officer
j**@curemark.comWilliam Mcintyre
Senior VP, Global Regulatory Affairs
w**@curemark.comElisa Zinberg
Senior Vice President, Operations
e**@curemark.comSaira Ramasastry
Corporate & Business Development Head
s**@curemark.comPhone Curemark
Chief Executive Officer
p**@curemark.comEbrahim Semary
Regional Sales Manager
e**@curemark.comSara Deutsch
Chief of Staff At Curemark
s**@curemark.comJames Fallon
Research Intern
j**@curemark.comCarmita Depasquale
Manager, Clinical Trial
c**@curemark.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
2.37 M
-
Page views per visitor
1.0
-
Daily time
2:11
-
Bounce Rate
30.8 %
Location
Unlock unlimited leads
Similar Companies
Knopp Biosciences LLC
knoppbio.com- Founded in 2004
- Location: Pittsburgh, PA
- Annual Revenue: $5.2M
- Employees: 20
- Knopp Biosciences is a drug discovery and development company focused on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership.
CymaBay Therapeutics
cymabay.com- Founded in 1990
- Location: Newark, CA
- Annual Revenue: $20.3M
- Employees: 59
- CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX...
PhaseBio Pharmaceuticals
phasebio.com- Founded in 2002
- Location: Malvern, PA
- Annual Revenue: $10.9M
- Employees: 60
- PhaseBio is focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
Beauty and Propolis
tigrispharma.com- Founded in 2005
- Location: Bonita Springs, FL
- Annual Revenue: $5.9M
- Employees: 22
- Tigris Pharmaceuticals is a biopharmaceutical company developing therapeutic technologies for cancer and other unmet medical needs.
Alzheon
alzheon.com- Founded in 2013
- Location: Framingham, MA
- Annual Revenue: $3.8M
- Employees: 16
- Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Rallybio
rallybio.com- Founded in 2018
- Location: Farmington, CT
- Annual Revenue: $11.8M
- Employees: 40
- Rallybio is a clinical stage biotechnology company that is focused on discovering, developing, and delivering transformative therapies for rare diseases. The company is built around a team of seasoned industry leaders who are dedicated to improving the...
Key Information
- Name: Curemark LLC
- Category: Biotechnology
- Industry: Pharmaceutical Company
- SIC: 28; 283
- NAICS: 32541; 5419
See similar companies
-
By City Rye Small Pharmaceutical Company in Rye Mid-size Pharmaceutical Company in Rye Biotechnology in Rye Small Biotechnology in Rye Mid-size Biotechnology in Rye
-
By State NY Small companies in NY Biotechnology in NY Small Biotechnology in NY Mid-size Biotechnology in NY Small Pharmaceutical Company in NY Mid-size Pharmaceutical Company in NY
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company Biotechnology and Pharmaceutical Company
-
Firmographic data G Score of 3 Founded in 2006 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 5419 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Curemark LLC's headquarters are located at 411 Theodore Fremd Avenue Rye, NY 10580.
Curemark LLC's official website is curemark.com
Curemark LLC's annual revenue is $4.6 M.
Curemark LLC's SIC: 28; 283
Curemark LLC's NAICS: 32541; 5419.
Curemark LLC has 16 employees
Curemark LLC is in the industry of Biotechnology.
